Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Illumina, Inc.

Market Cap 25.25B 21.76B 20.03B 18.79B 35.3B 2,386B 35.65B 237B 92.49B 1,169B 94.76B 92.75B 4,044B P/E Ratio 2026 *
35.6x
P/E Ratio 2027 * 29.5x
Enterprise Value 25.77B 22.21B 20.44B 19.18B 36.03B 2,436B 36.39B 242B 94.41B 1,193B 96.72B 94.67B 4,127B EV / Sales 2026 *
5.64x
EV / Sales 2027 * 5.19x
Free-Float
75.39%
Yield 2026 *
-
Yield 2027 * -
1 day+3.68%
1 week+5.60%
Current month+2.41%
1 month+17.08%
3 months+40.31%
6 months+23.70%
Current year+27.24%
1 week 159.34
Extreme 159.34
168
1 month 138.64
Extreme 138.64
177.22
Current year 112.65
Extreme 112.65
177.22
1 year 88
Extreme 88
177.22
3 years 68.7
Extreme 68.7
203.19
5 years 68.7
Extreme 68.7
526
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 2023-09-24
Director of Finance/CFO 50 2024-04-14
Chief Tech/Sci/R&D Officer 55 2025-05-28
Director TitleAgeSince
Director/Board Member 65 2016-07-27
Director/Board Member 66 2016-12-31
Director/Board Member 65 2019-02-04
Date Insider Type Main position Quantity % Market Cap.
06-04Sell

Head of Human Resources

-783 0.0005%
06-01Sell

Head of Human Resources

-784 0.0005%
05-31
Corvex Management LP
SellCompany -235,000 0.1553%
Change 5-day change 1-year change 3-year change Capi.($)
+3.68%+5.60%+91.98%-20.50% 25.25B
+0.93%+0.87%+17.62%-11.47% 176B
+1.34%-0.49%-18.67%+26.89% 148B
+0.56%-1.32%-9.75%-25.63% 128B
-0.32%-3.98%-53.12%-13.38% 69.5B
+1.37%+0.50%+14.81%-5.49% 49.68B
+0.33%-0.03%-23.81%-33.56% 45.26B
+0.58%-1.58%+11.54%+7.72% 36.88B
+0.63%-1.54%+4.52%+33.45% 35.13B
-0.64%+0.14%-10.37%-18.13% 29.46B
Average +0.89%-0.26%+2.48%-6.01% 74.29B
Weighted average by Cap. +0.86%-0.43%-3.14%-4.91%

Financials

2026 *2027 *
Net sales 4.57B 3.94B 3.63B 3.4B 6.39B 432B 6.45B 42.86B 16.74B 212B 17.15B 16.79B 732B 4.83B 4.16B 3.83B 3.6B 6.75B 457B 6.82B 45.31B 17.7B 224B 18.13B 17.75B 774B
Net income 718M 618M 569M 534M 1B 67.81B 1.01B 6.73B 2.63B 33.21B 2.69B 2.64B 115B 861M 742M 683M 641M 1.2B 81.41B 1.22B 8.08B 3.16B 39.86B 3.23B 3.16B 138B
Net Debt 522M 450M 414M 388M 730M 49.33B 737M 4.89B 1.91B 24.16B 1.96B 1.92B 83.59B -160M -138M -127M -119M -223M -15.1B -226M -1.5B -585M -7.39B -599M -587M -25.58B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
26-06-15 166.89 $ +3.68% 2,159,189
26-06-12 160.97 $ -3.15% 1,498,534
26-06-11 166.21 $ +2.30% 1,487,031
26-06-10 162.47 $ +1.52% 2,757,735
26-06-09 160.03 $ +1.26% 1,455,111
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
166.89USD
Average target price
147.17USD
Spread / Average Target
-11.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!